Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ELVN
ELVN News & Events
-
Add to Watchlist
Trade ELVN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ELVN News
Helen Collins Sells 40,000 Shares of Enliven Therapeutics
Mar 28 2026
NASDAQ.COM
Enliven's CMO Exercises and Sells Stock Options for $1.2 Million
Mar 28 2026
Fool
Enliven's CMO Sells 40,000 Shares for $1.2 Million
Mar 28 2026
Yahoo Finance
Terns Acquisition Sparks Hope for Enliven Therapeutics' Blood Cancer Pipeline
Mar 25 2026
stocktwits
ENLIVEN THERAPEUTICS INC: MIZUHO INCREASES TARGET PRICE FROM $41 TO $45
Mar 25 2026
moomoo
Enliven Therapeutics (ELVN.US) Officer Plans to Sell $3.08 Million in Common Stock via Form 144
Mar 24 2026
moomoo
Enliven Therapeutics Q4 Earnings Miss Expectations
Mar 03 2026
seekingalpha
Enliven Therapeutics Executive Sells 20,000 Shares
Feb 01 2026
Fool
Show More News
ELVN Events
No data
ELVN Monitor News
Enliven Therapeutics stock rises amid sector rotation
Apr 07 2026
Enliven Therapeutics' ELVN-001 Gains Attention Amid Merck's Acquisition
Mar 31 2026
Enliven Therapeutics' ELVN-001 Gains Attention Amid Merck's Acquisition
Mar 26 2026
Mizuho raises target price for Enliven Therapeutics to $45
Mar 25 2026
Enliven Therapeutics' ELVN-001 Shows Promising Trial Results
Jan 08 2026
ELVN Earnings Analysis
No Data
People Also Watch
